|
|
||||||||
Articles |
Department of Medicine, University Hospital of Tromso, Tromso, Norway. medrj@rito.no
OBJECTIVE: To study associations between serum ionised calcium, serum parathyroid hormone (PTH) and blood pressure. DESIGN: A population based, cross-sectional study was used.Methods: Blood pressure, body mass index, serum ionised calcium and serum PTH were measured in 460 males and 486 females in the Tromso study in 1994/1995. None were on medication for hypertension. The data were analysed with a multiple linear regression model. RESULTS: When looking at subjects with serum ionised calcium<1.39mmol/l, there was a significant negative association (P<0.01) between serum ionised calcium and PTH. There was no association between blood pressure and serum ionised calcium. In both sexes there was a significant positive association between age and serum PTH (P<0.01). For women, but not for men, there was a significant positive association between serum PTH and systolic and diastolic blood pressure (P<0.01). Within each age group there was a difference in both systolic and diastolic blood pressure of 3-10mmHg between the upper and lower serum PTH halves of the female population. Females with hypertension had significantly higher serum PTH levels than the normotensive females (P<0.01). CONCLUSION: Serum PTH is strongly and positively associated with blood pressure in women.
This article has been cited by other articles:
![]() |
J. P Reis, D. von Muhlen, and E. R Miller III Relation of 25-hydroxyvitamin D and parathyroid hormone levels with metabolic syndrome among US adults. Eur. J. Endocrinol., July 1, 2008; 159(1): 41 - 48. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P. Reis, D. von Muhlen, D. Kritz-Silverstein, D. L. Wingard, and E. Barrett-Connor Vitamin D, Parathyroid Hormone Levels, and the Prevalence of Metabolic Syndrome in Community-Dwelling Older Adults Diabetes Care, June 1, 2007; 30(6): 1549 - 1555. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Hagstrom, E. Lundgren, J. Rastad, and P. Hellman Metabolic abnormalities in patients with normocalcemic hyperparathyroidism detected at a population-based screening. Eur. J. Endocrinol., July 1, 2006; 155(1): 33 - 39. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Jorde, K. Waterloo, H. Storhaug, A. Nyrnes, J. Sundsfjord, and T. G. Jenssen Neuropsychological Function and Symptoms in Subjects with Subclinical Hypothyroidism and the Effect of Thyroxine Treatment J. Clin. Endocrinol. Metab., January 1, 2006; 91(1): 145 - 153. [Abstract] [Full Text] [PDF] |
||||
![]() |
L Maimoun, D Simar, D Malatesta, C Caillaud, E Peruchon, I Couret, M Rossi, and D Mariano-Goulart Response of bone metabolism related hormones to a single session of strenuous exercise in active elderly subjects Br. J. Sports Med., August 1, 2005; 39(8): 497 - 502. [Abstract] [Full Text] [PDF] |
||||
![]() |
R Jorde, F Saleh, Y Figenschau, E Kamycheva, E Haug, and J Sundsfjord Serum parathyroid hormone (PTH) levels in smokers and non-smokers. The fifth Tromso study Eur. J. Endocrinol., January 1, 2005; 152(1): 39 - 45. [Abstract] [Full Text] [PDF] |
||||
![]() |
F.N Saleh, H Schirmer, J Sundsfjord, and R Jorde Parathyroid hormone and left ventricular hypertrophy Eur. Heart J., November 2, 2003; 24(22): 2054 - 2060. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Sato, M. Kaji, N. Metoki, K. Satoh, and J. Iwamoto Does compensatory hyperparathyroidism predispose to ischemic stroke? Neurology, February 25, 2003; 60(4): 626 - 629. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |